Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Lopinavir/Ritonavir in Salvage Therapy for PI Resistant HIV
NCT00247143Phase 2Unknown
- Sponsor
- Lampire Biological Laboratories
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Lampire Biological Laboratories. Status: unknown.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00247143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247143.